KayoThera Nominates Inhibitor of the Retinoid Pathway as a Development Candidate
18 Sep 2023 //
BUSINESSWIRE
KayoThera Strengthens Financial Position with $5.2 Million in Grant
19 Jul 2023 //
BUSINESSWIRE
18 Sep 2023 //
BUSINESSWIRE
19 Jul 2023 //
BUSINESSWIRE